pemoline sold brand name cylert among others stimulant medication used treatment attentiondeficit hyperactivity disorder adhd discontinued countries due rare serious problems liver medication taken side effects pemoline include insomnia decreased appetite abdominal pain irritability rarely medication cause serious liver damage result liver transplantation pemoline psychostimulant acts selective dopamine reuptake inhibitor releasing hence functions indirect agonist dopamine pemoline little effect norepinephrine hence minimal cardiovascular sympathomimetic effects contrast many pemoline synthesized discovered stimulant used treatment adhd withdrawn due liver toxicity many countries including united however remains available japan treatment narcolepsy lower doses used pemoline schedule iv controlled substance united states due relation stimulants potential seems less misuse potential pemoline used treatment adhd also used treatment excessive daytime medication typically used doses mg per day treatment adhd effective dose people range onset action pemoline gradual therapeutic benefits may occur third fourth weeks may due cautious low initial starting dose mg gradual titration dose upwards several pemoline available form mg oral immediaterelease tablets cylert well mg oral immediaterelease chewable provided mainly form free base also magnesium side effects pemoline include insomnia decreased appetite abdominal pain irritability minimal cardiovascular sympathomimetic side pemoline described lowerefficacymilder stimulant classical stimulants like amphetamines methylphenidate said fewer side effects rarely pemoline implicated causing fda recommended regular liver tests performed treated since introduced linked least cases liver failure resulted liver replacement death approximately patients taking drug show elevated levels liver transaminase enzymes marker liver toxicity though serious cases rare children adhd prescribed pemoline united states canada alone approximate years available plus smaller number adults prescribed indications including prescriptions rest world number liver failure cases statistically large however reactions proved idiosyncratic unpredictable patients sometimes taking drug issue months even years suddenly developing severe liver toxicity clear relationship characteristic liver pathology findings patients showed little one week first appearance jaundice complete liver failure patients developed liver failure showed elevated liver transaminase levels tested hand cases liver failure associated pemoline japan although used lower doses prescribed niche indication narcolepsy overdose pemoline may present choreoathetosis stimulants monoamine oxidase inhibitors contraindicated pemoline pharmacodynamics pemoline poorly understood precise mechanism action hasnt definitively however pemoline similar activity effects psychostimulants animals medication appears act dopamine reuptake inhibitor releasing increasing dopamine levels brain functions indirect agonist dopamine contrast stimulants pemoline appears produce significant central peripheral noradrenergic result minimal cardiovascular sympathomimetic pemoline described selective dopamine reuptake inhibitor weakly stimulates dopamine drugs like dextroamphetamine methylphenidate classified schedule ii considerable misuse potential pemoline listed schedule iv studies conducted primates pemoline fails demonstrate potential thought little potential abuse nonetheless misuse may theoretically occur owing similarity studies pharmacokinetics pemoline humans time peak levels pemoline peak levels reported range steadystate levels pemoline reached pemoline variously reported significant plasma protein binding plasma protein pemoline metabolized metabolites include pemoline conjugate pemoline dione mandelic acid unidentified polar pemoline excreted mainly kidneys around excreted unchanged form minor amounts present elimination halflife pemoline halflife hours children may increase hours relatively long halflife pemoline allows oncedaily differences pharmacokinetics pemoline found conventional tablets chewable tablets swallowed chewable tablets pemoline member class structurally related members class including aminorex clominorex cyclazodone fenozolone fluminorex thozalinone salts pemoline use pemoline magnesium free base conversion ratio pemoline iron pemoline copper pemoline nickel pemoline rubidium pemoline calcium pemoline chromium chelates identical weight salt mentioned pemoline free base pemoline cobalt strontium silver barium lithium sodium potassium zinc manganese caesium research chemicals produced situ others lanthanide pemoline salts pemoline cerium prepared pemoline beryllium would presumably toxic pemoline first synthesized activity discovered pemoline approved treatment adhd united states cases serious liver toxicity associated death related pemoline children adolescents reported united states food drug administrations medwatch serious liver toxicity pemoline first described medical literature letters clinicians littleaware liver toxicity pemoline warnings liver toxicity pemoline added united states food drug administration fda label medication december black box warning added june along requirements written consent frequent monitoring liver warnings followed publication liver toxicity however findings suggested clinicians poorly followed fdas directives use case sales pemoline united states increased declined pemoline withdrawn due liver toxicity united kingdom september canada september united states abbott laboratories voluntarily withdraw pemoline united states market may fda withdrew approval generic pemoline november pemoline remains available japan treatment narcolepsy pemoline generic name drug inntooltip international nonproprietary name usantooltip united states adopted name bantooltip british approved pemoline formerly marketed brand names cylert betanamin ceractiv hyperilex kethamed ronyl stimul tamilan tradon tropocer pemoline marketed united states canada united kingdom belgium luxembourg spain germany switzerland remains available japan treatment narcolepsy however medication said rarely used japan narcolepsy niche indication clinicians wary liver toxicity associated convention psychotropic substances schedule iv controlled pemoline schedule iv nonnarcotic stimulant controlled substance dea acscn subject annual manufacturing pemoline studied reported effective treatment fatigue due multiple sclerosis hivrelated httpsenwikipediaorgwikipemoline